Catalyst
Slingshot members are tracking this event:
Johnson & Johnson (JNJ) launches new data of Stelara treating adults with moderate to severe active Crohn's disease
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| JNJ | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Feb 17, 2017
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Stelara, Crohn's Disease, Remission
